Stock TBIO TELESIS BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Telesis Bio, Inc.

Equities

TBIO

US1920032000

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-21 pm EDT 		5-day change 1st Jan Change
4.27 USD -5.32% Intraday chart for Telesis Bio, Inc. +1.30% -40.55%
May. 09 Earnings Flash (TBIO) TELESIS BIO Reports Q1 Revenue $3.4M MT
May. 09 Telesis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Telesis Bio: Q1 Earnings Snapshot
AQ
Earnings Flash (TBIO) TELESIS BIO Reports Q1 Revenue $3.4M
MT
Telesis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Telesis Bio Reports First Quarter 2024 Financial Results
GL
Telesis Bio Announces Reverse Stock Split
GL
Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership
GL
Telesis Bio, Inc. Announces Appointment of Eric Esser to the Board of Directors
CI
Telesis Bio Inc. Announces Strategic Focus on Game-Changing Gibson Sola Enzymatic DNA Synthesis Platform and BioXp mRNA Solutions
CI
Telesis Bio, Inc. Announces Chief Executive Officer Changes
CI
Telesis Bio : Shareholder Meeting - Form 8-K
PU
Telesis Bio: Q4 Earnings Snapshot
AQ
Earnings Flash (TBIO) TELESIS BIO Reports Q4 Revenue $7M
MT
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
GL
Telesis Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Telesis Bio, Inc. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023
CI
Stocks Making Waves: Insights into Key Developments and Potential VTAK, TBIO, OCEA, ONMD, KZIA
AQ
Telesis Bio, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
GL
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
AQ
Thinking about buying stock in Telesis Bio, Sellas Life Sciences, Mitek Systems, Monopar Therapeutics, or Inpixon?
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TBIO Stock
  4. News Telesis Bio, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW